Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
15.66 USD | -0.38% | -3.15% | +22.82% |
May. 07 | Curis, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
May. 07 | Transcript : Curis, Inc., Q1 2024 Earnings Call, May 07, 2024 |
Financials (USD)
Sales 2024 * | 8.16M | Sales 2025 * | 8.76M | Capitalization | 92.3M |
---|---|---|---|---|---|
Net income 2024 * | -47M | Net income 2025 * | -53M | EV / Sales 2024 * | 11.3 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 10.5 x |
P/E ratio 2024 * |
-2.53
x | P/E ratio 2025 * |
-3.22
x | Employees | 49 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.82% |
Latest transcript on Curis, Inc.
1 day | -0.38% | ||
1 week | -3.15% | ||
Current month | +2.02% | ||
1 month | +2.49% | ||
3 months | +54.44% | ||
6 months | +189.46% | ||
Current year | +22.82% |
Managers | Title | Age | Since |
---|---|---|---|
James Dentzer
CEO | Chief Executive Officer | 57 | 16-03-28 |
Diantha Duvall
DFI | Director of Finance/CFO | 52 | 22-07-25 |
Chief Tech/Sci/R&D Officer | - | 22-01-02 |
Members of the board | Title | Age | Since |
---|---|---|---|
Kenneth Kaitin
BRD | Director/Board Member | 71 | 03-10-31 |
Martyn Greenacre
CHM | Chairman | 82 | 00-02-13 |
James Dentzer
CEO | Chief Executive Officer | 57 | 16-03-28 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 0 M€ | 0.00% | - | |
0.01% | 2 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-05-13 | 15.66 | -0.38% | 23,347 |
24-05-10 | 15.72 | -4.78% | 12,065 |
24-05-09 | 16.51 | +0.98% | 27,636 |
24-05-08 | 16.35 | +0.93% | 15,118 |
24-05-07 | 16.2 | +0.19% | 17,446 |
Delayed Quote Nasdaq, May 13, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+22.82% | 92.3M | |
+26.37% | 48.16B | |
-1.01% | 41.73B | |
+46.00% | 41.03B | |
-5.31% | 28.77B | |
+9.34% | 25.59B | |
-21.69% | 18.96B | |
+6.23% | 12.92B | |
+26.99% | 12.03B | |
-3.38% | 11.77B |
- Stock Market
- Equities
- CRIS Stock